Contradictions in Corporate Social Responsibility
The pharmaceutical industry and medicines for the poor
Posted in category:
Publication
Published on:
As a response to the health crises in developing countries and the insufficient access to affordable drugs, around 90 of what are known as Global Public-Private Partnerships (GPPPs) have been set up over the last decade. Although these partnerships are varied, they all share some basic characteristics. They form collaborations or partnerships made up of a United Nations (UN) body such as the World Health Organization (WHO), national governments, corporations, foundations and non-governmental organisations (NGOs). The world’s largest pharmaceutical companies are also involved in these partnerships, and they provide drugs to the partnerships, usually at a reduced price or as a donation.
Partners
-
Wemos
Publication
Related news
-
A major legal win for the Ka’apor People in Brazil against the carbon offset industryPosted in category:News
Aintzane MárquezPublished on: -
CCS smokescreen: the Port of Rotterdam’s corporate-driven energy transitionPosted in category:Long read
Joanna CabelloPublished on: -
